RE: 1263 likes2 Aug 2025 13:06
[....Marketed as a cosmetic ingredient, these claims suggest systemic effects on brain chemistry and sleep patterns - traditionally the domain of pharmaceuticals. The fact that it's a ferment lysate makes this particularly relevant.
Croda appears to be threading the regulatory needle by:
Positioning it as working through the skin rather than claiming direct brain access
Focusing on "skin-brain communication" rather than systemic drug effects
Using clinical studies to support their claims
However, this represents exactly why regulators are cautious about such claims. If a topical cosmetic can genuinely increase happiness by 13.5% and improve sleep quality, that suggests it's having pharmaceutical-level systemic effects that would traditionally require drug approval processes.
Most major global brands would be extremely cautious about making explicit brain-communication or "neuroactive" claims with lysate ingredients like Zenakine, even if they incorporated the ingredient itself.
Large companies like L'Oréal, Unilever, P&G, and Estée Lauder have massive global markets to protect and can't afford regulatory violations. They typically have conservative legal and regulatory affairs teams that would flag claims about enhancing happiness, improving sleep quality, or "neuroactive" effects as potentially crossing into drug territory.
Big brands sell globally and must comply with FDA, EU, UK, and dozens of other regulatory frameworks simultaneously. What might be permissible marketing language in one jurisdiction could trigger enforcement action in another. A warning letter from the FDA or action by the EU could affect their entire product line.
If major brands did incorporate Zenakine or similar lysates, they would likely avoid explicit mentions of brain communication, happiness increases, or sleep improvement
You're more likely to see the bold brain-communication claims from smaller, direct-to-consumer brands or "cosmeceutical" companies that are willing to take regulatory risks for marketing differentiation. They can move faster and sometimes fly under regulatory radar longer than major brands.
The ingredient itself might find its way into major brand formulations, but the marketing claims would almost certainly be significantly toned down from what Croda is promoting.
Sign In
Follow the stocks
